-
Study aim
-
Explaining the effect of eight weeks of aerobic exercise and omega-3 intake on IL-1β and MCP-1 levels in overweight and obese women
-
Design
-
Clinical trial with control group, with parallel groups, one-way blind, randomized, on 40 patients
-
Settings and conduct
-
Pre-test blood samples will be collected prior to the 8-week training intervention. In the next stage, the subjects of the aerobic exercise group and aerobic exercise + omega 3 will participate in the desired exercise program for 8 weeks. Each aerobic exercise session will consist of 47 minutes of brisk walking or jogging with an intensity equivalent to 70-60% of the maximum heart rate, which is performed three times a week.Before and after each aerobic exercise session, warm-up and cooling will be performed, respectively. Consumption of omega-3 will be considered 2000 mg per day.48 hours after the last exercise session and in order to eliminate the acute effects of the last session of aerobic exercise and omega 3 consumption, the subjects will be present again in the post-test phase for blood sampling. 7 ml of blood will be taken from each subject while sitting and from a brachial vein. The blood samples are then centrifuged.
-
Participants/Inclusion and exclusion criteria
-
Overweight and obese women between the ages of 25 and 40, not participating in regular exercise for the past year, not having type 2 diabetes, not having other chronic diseases such as cancer, not having a history of heart disease, and lack of physical and medical restrictions to participate in exercise
-
Intervention groups
-
Subjects will be randomly divided into 4 groups including placebo, omega 3, aerobic exercise and aerobic exercise + omega 3
-
Main outcome variables
-
Study level of IL-1β and MCP-1 in overweight and obese women, weight loss, Study the risk of inflammatory diseases